OROPHARYNGEAL CANCER RECURRENT

OROPHARYNGEAL CANCER RECURRENT was reported 6 times

OROPHARYNGEAL CANCER RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE 1 0.0032
1 MECLIZINE HCL 12.5 MG 1 0.0001
2 MECLIZINE HYDROCHLORIDE 1 0.0001
3 AZACITIDINE 1 0.0000
4 CETUXIMAB 1 0.0000
5 CISPLATIN 1 0.0000
6 DIPHENHYDRAMINE HYDROCHLORIDE 1 0.0000
7 RITUXIMAB 1 0.0000
8 LISINOPRIL 1 0.0000
9 DUPILUMAB 1 0.0000